Viewing Study NCT06619561


Ignite Creation Date: 2025-12-24 @ 12:00 PM
Ignite Modification Date: 2026-01-27 @ 3:58 AM
Study NCT ID: NCT06619561
Status: RECRUITING
Last Update Posted: 2025-12-15
First Post: 2024-09-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
Sponsor: Deciphera Pharmaceuticals, LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Graft-Versus-Host Disease (cGVHD) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Allogeneic hematopoietic stem cell transplant (HSCT) View
None Graft-Versus-Host Disease View
None GVHD View
None cGVHD View
None Graft versus host disease View
None Immune System Diseases View
None Organizing Pneumonia View
None Bronchiolitis Obliterans View
None Bronchiolitis View
None Bronchial Diseases View
None Respiratory Tract Diseases View
None Lung Diseases, Obstructive View
None Lung Diseases View
None Bronchiolitis Obliterans Syndrome View
None Graft vs Host Disease View
None Sclerosis View
None Fibrosis View
None Hematopoietic stem cell transplantation View
None Liver diseases View